Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma symbols : LLY save search
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
Published: 2023-11-30 (Crawled : 08:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.01%
H: 0.81%
C: -0.07%
FGEN | $0.9504 -3.44% 240K
|
Health Technology
|
| O: 6.3%
H: 11.13%
C: 4.23%
pharma
Viva Biotech's Portfolio Company DTx Pharma Reached the Acquisition Agreement with Novartis
Published: 2023-07-18 (Crawled : 07:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.04%
H: 1.43%
C: 0.95%
pharma acquisition novartis agreement
DTx Pharma announces acquisition by Novartis
Published: 2023-07-17 (Crawled : 13:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.0%
H: 0.26%
C: -0.51%
pharma acquisition novartis
Historic Actos RICO Class Action Against Big Pharma Could be Worth Billions
Published: 2023-06-05 (Crawled : 00:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.8%
H: 0.23%
C: -1.06%
pharma
Kyowa Kirin Appoints Pharma Industry Leader Steve Schaefer as President, North America to Manage Next Phase of Growth
Published: 2023-04-11 (Crawled : 13:20) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.21%
H: 0.28%
C: -1.01%
america pharma growth
Global Psoriasis Therapeutics Market Report to 2031 - Featuring Abbvie, Amgen, Bausch Health, LEO Pharma and Novan Among Others
Published: 2023-01-25 (Crawled : 21:00) - prnewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
VTRS | News A | $11.61 0.52% 1.1M
|
Health Technology
|
| O: -0.69%
H: 0.87%
C: 0.69%
NVS | News | $98.67 0.33% 260K
|
Health Technology
|
| O: -1.97%
H: 0.11%
C: -1.25%
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.36%
H: 0.34%
C: -0.85%
BHC | $8.52 -0.47% 230K
|
Health Technology
|
| O: 1.91%
H: 3.28%
C: -0.23%
ABBV | News | $166.41 -0.83% 860K
|
Health Technology
|
| O: 0.09%
H: 0.53%
C: -0.35%
AMGN | News | $268.16 -1.78% 290K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: -0.65%
leo pharma global report therapeutics psoriasis market
Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa
Published: 2022-12-14 (Crawled : 10:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.1%
H: 2.9%
C: 1.25%
pharma collaboration insulin africa
DelveInsight Evaluates a Robust RNA Interference Pipeline as Key 85+ Pharma Companies Set Foot in the RNA Interference Space
Published: 2022-11-01 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% 0
|
Health Technology
|
| O: 7.74%
H: 0.17%
C: 0.17%
JNJ | News | $147.46 -0.72% 820K
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -4.49%
H: 3.81%
C: 1.95%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MRNA | News S | $105.05 -3.49% 480K
|
Health Technology
|
| O: 2.95%
H: 2.66%
C: -0.1%
CVAC | $2.3 -8.37% 390K
|
Health Technology
|
| O: 1.1%
H: 3.4%
C: -1.36%
BNTX | News | $86.39 -1.93% 77K
|
Health Technology
|
| O: 4.54%
H: 4.25%
C: 0.13%
ALNY | $142.22 -1.1% 25K
|
Health Technology
|
| O: 1.06%
H: 2.53%
C: 1.75%
space pharma companies set
Jacobio Pharma to Collaborate with Merck on Clinical Trial of JAB-21822 in Combination with Cetuximab
Published: 2022-10-13 (Crawled : 02:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -1.68%
H: 4.47%
C: 4.07%
jab-2182 pharma trial
Tact.ai Welcomes Two New Pharma Executives as Board Advisors to Accelerate Innovation in Life Sciences Customer Engagement
Published: 2022-10-06 (Crawled : 15:20) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -1.16%
H: 3.45%
C: 1.53%
pharma sciences life innovation
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published: 2022-07-19 (Crawled : 01:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.72%
H: 1.02%
C: 0.65%
INCY | $51.28 -0.89% 87K
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
treatment designation pharma drug application granted review china
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published: 2022-07-20 (Crawled : 01:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.27%
H: 0.22%
C: -1.55%
INCY | $51.28 -0.89% 87K
|
Health Technology
|
| O: 2.32%
H: 1.21%
C: 0.99%
treatment designation pharma drug application granted review china
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published: 2022-07-19 (Crawled : 17:00) - prnewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.72%
H: 1.02%
C: 0.65%
INCY | $51.28 -0.89% 87K
|
Health Technology
|
| O: -0.83%
H: 0.0%
C: 0.0%
treatment designation pharma drug application granted review china
DTx Pharma Appoints Peter Condon as Chief Business Officer
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
pharma
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $166.41 -0.83% 860K
|
Health Technology
|
| O: 0.06%
H: 1.27%
C: -0.44%
SNY | News | $49.085 5.31% 1.2M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
pharma
Zealand Pharma Announces Appointment of David M. Kendall, M.D., as Chief Medical Officer
Published: 2022-06-02 (Crawled : 07:00) - globenewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
ZEAL | $17.59 1.21% -4.21%
|
Health Technology
|
| O: -7.14%
H: 0.0%
C: -1.6%
MNKD | $4.145 -1.07% 160K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: 0.0%
pharma
DTx Pharma Appoints Michael Huang, MD as Chief Medical Officer
Published: 2022-05-31 (Crawled : 12:20) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 1.84%
H: 0.0%
C: 0.0%
pharma
DTx Pharma Announces Appointment of Kathie M. Bishop to its Board of Directors
Published: 2022-05-02 (Crawled : 12:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
pharma
180 Degree Capital Corp. Receives $12.3 Million, or $1.19 Per Share, in Cash From Buyout of Its Potential Future Milestones From the Acquisition of Petra Pharma Corporation by Lilly
Published: 2022-04-28 (Crawled : 13:20) - globenewswire.com
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 4.44%
H: 1.53%
C: 0.43%
TURN | $3.91 170
|
Finance
|
| O: 1.1%
H: 4.21%
C: 2.96%
acquisition pharma corporation potential
DTx Pharma to Participate in the 8th Annual Fall Private Company Showcase with Solebury Trout and BMO
Published: 2021-10-07 (Crawled : 12:00) - biospace.com/
LLY | News | $724.615 -1.04% 480K
|
Health Technology
|
| O: 0.56%
H: 2.18%
C: 1.77%
pharma
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.22 61.0% 720K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.